Solifenacin in Overactive Bladder Syndrome

被引：0

作者：

Dene Simpson

Antona J. Wagstaff

机构：

[1] Adis International Limited,

来源：

Drugs & Aging | 2005年 / 22卷

关键词：

Oxybutynin; Urge Incontinence; Tolterodine; Solifenacin; Moderate Hepatic Impairment;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

▴ Solifenacin is a bladder-selective, muscarinic (M1 and M3) receptor antagonist. In animal studies, the selectivity of solifenacin for the bladder over the salivary glands was greater than that of tolterodine, oxybutynin, darifenacin or atropine.

引用

页码：1061 / 1069

页数：8

共 50 条

[1] Solifenacin in overactive bladder syndrome
Simpson, D
Wagstaff, AJ
[J]. DRUGS & AGING, 2005, 22 (12) : 1061 - 1069
[2] Solifenacin in overactive bladder syndrome
Payne, CK
[J]. DRUGS, 2006, 66 (02) : 175 - 190
[3] Solifenacin in Overactive Bladder Syndrome
Christopher K. Payne
[J]. Drugs, 2006, 66 : 175 - 190
[4] Solifenacin in the management of the overactive bladder syndrome
Robinson, D
Cardozo, L
[J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2005, 59 (10) : 1229 - 1236
[5] Solifenacin in overactive bladder syndrome: pharmacoeconomic analysis
Iannazzo, Sergio
Pradelli, Lorenzo
[J]. FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2008, 9 (01) : 5 - 14
[6] Solifenacin in overactive bladder syndrome: profile report
[J]. Drugs & Therapy Perspectives, 2006, 22 (5) : 5 - 6
[7] Solifenacin in overactive bladder syndrome - A viewpoint by Scott Serels
Serels, S
[J]. DRUGS & AGING, 2005, 22 (12) : 1070 - 1071
[8] The Efficacy and Safety of Solifenacin in Patients with Overactive Bladder Syndrome
Oreskovic, Slavko
But, Igor
Banovic, Maja
Goldstajn, Marina Sprem
[J]. COLLEGIUM ANTROPOLOGICUM, 2012, 36 (01) : 243 - 248
[9] Solifenacin in neurogenic overactive bladder
Spinelli, M.
Citeri, M.
Zanollo, L.
Redaelli, T.
[J]. EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 273 - 273
[10] Solifenacin and darifenacin for overactive bladder
不详
[J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2005, 47 (1204): : 23 - 24

← 1 2 3 4 5 →